SCHEMBL24525575

SCHEMBL24525575

CCCn1c2ccccc2c(=O)c2cc(OC)ccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX4 Q99571 1/20 0.58
PTGS2 P35354 2/20 0.56
L3MBTL1 Q9Y468 5/20 0.54
ALDH1A1 P00352 4/20 0.54
KMT2A Q03164 2/20 0.54
HPGD P15428 2/20 0.54
KDM4E B2RXH2 2/20 0.54
MAPT P10636 2/20 0.54
MEN1 O00255 1/20 0.54
HTT P42858 1/20 0.54
HSD17B10 Q99714 1/20 0.54
CNR2 P34972 2/20 0.53
ACHE P22303 1/20 0.53
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
MARK4 Q96L34 1/20 0.50
HCRTR1 O43613 1/20 0.49
ATM Q13315 1/20 0.49
NTRK1 P04629 3/20 0.48
GRIK2 Q13002 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30213498 0.92 KDM4E (0.56) P2RX4PTGS2L3MBTL1ALDH1A1KMT2A
SCHEMBL12611201 0.92 KDM4E (0.56) P2RX4PTGS2L3MBTL1ALDH1A1KMT2A
SCHEMBL29717634 0.92 KDM4E (0.56) P2RX4PTGS2L3MBTL1ALDH1A1KMT2A
SCHEMBL11382265 0.89 ALDH1A1 (0.68) P2RX4PTGS2L3MBTL1ALDH1A1KMT2A
SCHEMBL14160805 0.84 KDM4E (0.62) ALDH1A1KMT2AHPGDKDM4EHSD17B10
SCHEMBL6152266 0.84 L3MBTL1 (0.76) P2RX4PTGS2L3MBTL1ALDH1A1KMT2A
SCHEMBL14160792 0.84 PSEN1 (0.57) P2RX4PTGS2ALDH1A1CNR2
SCHEMBL13386557 0.83 ALDH1A1 (0.71) P2RX4ALDH1A1HPGDKDM4EMAPT
SCHEMBL28948755 0.82 DYRK1A (0.58) L3MBTL1ALDH1A1KMT2AHPGDKDM4E
SCHEMBL14280388 0.82 P2RX4 (0.77) P2RX4ALDH1A1KMT2AACHETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115698190-B Light stability simulation of macular pigment 强生视力健公司 2025-06-17 CN claimed
CN-115698190-B Light stability simulation of macular pigment 强生视力健公司 2025-06-17 CN disclosed
US-20250189826-A1 OPHTHALMIC DEVICES CONTAINING PHOTOSTABLE MIMICS OF MACULAR PIGMENT AND OTHER VISIBLE LIGHT FILTERS JOHNSON & JOHNSON VISION CARE, INC. 2025-06-12 US disclosed
CN-119365797-A Ophthalmic devices comprising light stable mimics of macular pigments and other visible light filters 强生视力健公司 2025-01-24 CN disclosed
CN-115698190-A Photostable simulation of macular pigment 强生视力健公司 2023-02-03 CN disclosed
US-20220194944-A1 PHOTOSTABLE MIMICS OF MACULAR PIGMENT JOHNSON & JOHNSON VISION CARE, INC. 2022-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220194944-A1 PHOTOSTABLE MIMICS OF MACULAR PIGMENT CRY1, PDE6C, PDE6A P2RX4 1069/4885PTGS2 1212/4885L3MBTL1 2761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.